30 Day Trial

Integra LifeSciences Launches Panta 2 TTC Arthrodesis Nail


Integra LifeSciences introduced the Integra® Panta® 2 TTC Arthrodesis Nail System for tibio-talo-calcaneal fusion of the ankle. 

Panta 2’s carbon fiber targeting and compression device allows an unobstructed intra-op view of the nail to assist in positioning and verification that bone-to-bone contact is made. The device enables up to 12mm of compression to accommodate varying patient anatomies.      

Panta 2 joins the XT revision ankle as new products cited by company leadership that will reinvigorate growth in Integra's Orthopaedics and Tissue Technologies segment.

Sources: Integra LifeSciences; ORTHOWORLD Inc.